Zentek LtdZEN
Price$0.49

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Mar 2025
Market Price $0.49Price as of 1 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: -18.1%/yr (balance of the path).-13.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 6-13.9%Yr 7-9.6%Yr 8-5.4%Yr 9-1.2%Yr 103.0%
-18.1% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)-13.9%
Discount rate (cost of equity) 7.7%
Volatility vs market (adjusted beta)0.62

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetZentek LtdZENHealth Care
Valuation
P/E—
P/S855.1×
P/B3.4×
EV / Revenue862.8×
EV / EBITDA-12.0×
Profitability
Gross margin-74.8%
Operating margin-928.4%
Net margin-13,780.3%
FCF margin-8,625.2%
Returns
ROE-68.1%
ROA-54.6%
ROIC—
Growth
Revenue growth (YoY)—
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.07×
Current ratio1.25×
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.